Content
Protalix BioTherapeutics: Management Sounds Confident Despite CRL
Article By:
Avisol Capital Partners
Read
Wednesday, January 5, 2022 9:39 AM EDT
A spate of bad bureacratic luck - including the FDA letter explaining that Covid kept them from doing an inspection - has put PLX's Fabry disease drug in an uncompetitive position, but we reached out to management to learn more about the pipeline.
In this article: PLX
Annual Changes To The Nasdaq-100 Index
Article By:
NASDAQ GlobeNewswire
Read
Saturday, December 11, 2021 10:39 AM EDT
The reconstituted Nasdaq index for 2022 (effective Dec. 20, 2021) has six new members; they replace FOX, TCOM, INCY, CDW, CERN, and CHKP.
AWKNF: A Psychedelic's Stock Exhibiting Recent Price Appreciation
Article By:
James Coleman
Read
Wednesday, November 24, 2021 9:58 AM EDT
Awakn Health Sciences Corp's trading pattern over the past 10-day time span is an egregious example of a psychedelic stock that has exhibited recent price appreciation coupled with a surge in average daily volume.
In this article: AWKNF
Chemung Financial Corporation (CHMG) Announces Quarterly Dividend
Article By:
NASDAQ GlobeNewswire
Read
Saturday, November 20, 2021 11:33 PM EDT
Its Board of Directors has approved a quarterly cash dividend of $0.31 per share, payable on January 3, 2022.
In this article: CHMG
Awakn Life Sciences: Wake Up To The Huge Potential
Article By:
Lorimer Wilson
Read
Monday, November 1, 2021 11:52 AM EDT
The private global addiction treatment industry is currently valued at US$17.5 billion per year and forecast to increase to US$31.5 billion per year by 2027.
In this article: AWKNF
BankFinancial Corporation Declares Cash Dividend
Article By:
NASDAQ GlobeNewswire
Read
Sunday, October 31, 2021 1:00 AM EDT
The dividend will be payable on November 26, 2021 to stockholders of record on November 12, 2021.
In this article: BFIN
Tilray Q1 2022 Financial Results Show Little Improvement
Article By:
Lorimer Wilson
Read
Saturday, October 9, 2021 3:00 PM EDT
Tilray's stock has declined 21.8% since the end of its Q4 2021, and now at end of Q1'22 it's only up +27.0% YTD.
In this article: TLRY
Issuances In Prospect Capital Corporation Preferred Stock Offerings Exceed $350 Million Across Institutional, Registered Investment Advisor, Wirehouse, And Independent Private Wealth Investors
Article By:
NASDAQ GlobeNewswire
Read
Monday, September 27, 2021 4:10 PM EDT
Prospect Capital Corporation announced today that Prospect’s preferred stock offerings have exceeded $350 million in aggregate liquidation preference issuances since the initial closing in the quarter ending December 31, 2020.
In this article: PSEC
Moderna Reports Second Quarter Fiscal Year 2021 Financial Results And Provides Business Updates
Article By:
Business Wire
Read
Thursday, August 5, 2021 10:12 AM EDT
Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the second quarter of the fiscal year 2021.
In this article: MRNA
Humana Reports Second Quarter 2021 Financial Results; Maintains Full Year 2021 Adjusted EPS Financial Guidance
Article By:
Business Wire
Read
Wednesday, July 28, 2021 9:50 AM EDT
Humana Inc. today reported consolidated pretax income and diluted earnings per common share for the quarter ended June 30, 2021.
In this article: HUM
Nasdaq, Inc. Announces Proposed Senior Notes Offering
Article By:
NASDAQ GlobeNewswire
Read
Tuesday, July 27, 2021 9:49 AM EDT
Nasdaq, Inc. today announced that it plans to offer, subject to market and other conditions, Euro-denominated senior notes.
In this article: NDAQ
PLX Upcoming Volatility Creates Opportunity
Article By:
Moon Kil Woong
Read
Tuesday, July 27, 2021 9:01 AM EDT
PLX was up on FDA notice last year on a CRL postponement that its PDUFA review of PRX-102. In the meantime, phase III trials continue to provide more positive results. It is a stock worth watching.
Willis Towers Watson Increases Share Repurchase Program By $1 Billion; Announces Investor Day In September
Article By:
NASDAQ GlobeNewswire
Read
Monday, July 26, 2021 10:58 AM EDT
Willis Towers Watson announced that its Board of Directors approved an increase of $1 billion to its existing share repurchase program, which has approximately $500 million remaining on the current open-ended repurchase authority.
In this article: WLTW
Schlumberger Announces Second-Quarter 2021 Results
Article By:
Business Wire
Read
Friday, July 23, 2021 9:34 AM EDT
Schlumberger Limited today reported results for the second quarter 2021.
In this article: SLB
Virgin Galactic Successfully Completes First Fully Crewed Spaceflight
Article By:
Business Wire
Read
Sunday, July 11, 2021 9:14 PM EDT
Fourth spaceflight tests private astronaut and research experience; first in-flight livestream brings spaceflight experience to audiences around the world.
In this article: SPCE